These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 15425176)

  • 1. [Sulfapyrimidine in chemotherapy; clinical experiences with 6-sulfanilamido-2,4-dimethylpyrimidin, L 30 of Nordmark and Co..].
    HAUCH HJ; LUDWIG L; MULHENS K
    Z Gesamte Inn Med; 1950 Mar; 5(5-6):159-68. PubMed ID: 15425176
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative merits of 3, 4-dimethyl-5-sulfanilamido-isoxazole (gantrisin) and a sulfapyrimidine triple mixture; an evaluation of properties important at the bedside.
    LEHR D
    Antibiot Chemother (Northfield); 1953 Jan; 3(1):71-93. PubMed ID: 24542282
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical experiences with the new sulfonamide 5-methyl-3-sulfanilamido-isoxazole].
    HOCHULI E
    Schweiz Med Wochenschr; 1962 Dec; 92():1604-7. PubMed ID: 13963750
    [No Abstract]   [Full Text] [Related]  

  • 4. [S-Sulfanilamido- and 3-sulfanilamido-1,2,4-thiadiazole].
    WOERFFEL U; BEHNISCH R
    Arch Pharm Ber Dtsch Pharm Ges; 1962 Nov; 295/67():811-6. PubMed ID: 14001457
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative experimental studies on 5-methyl-3-sulfanilamido-isoxazole, other sulfanilamides and antibiotics].
    FUST B; BOEHNI E
    Schweiz Med Wochenschr; 1962 Dec; 92():1599-604. PubMed ID: 13945938
    [No Abstract]   [Full Text] [Related]  

  • 6. Biologically active nuclear-substituted sulfonamides. I. Chemical and physical properties of some nuclear-substituted sulfanilamido-2-thiazoles and their syntheses.
    QUAN SF; DANIELS TC; KUMLER WD
    J Am Pharm Assoc Am Pharm Assoc; 1954 Jun; 43(6 1):321-6. PubMed ID: 13174427
    [No Abstract]   [Full Text] [Related]  

  • 7. [2-Sulfanilamido-3-methoxypyrazine. Chemical, physicochemical, biological and therapeutic characteristics].
    ROCCHIETTA S
    Boll Chim Farm; 1961 Apr; 100():279-81. PubMed ID: 13742397
    [No Abstract]   [Full Text] [Related]  

  • 8. [6-Sulfanilamido-2,4-dimethylpyrimidine; contribution to sulfonamide therapy].
    KORNER H
    Dtsch Gesundheitsw; 1950 Jun; 5(23):727-8. PubMed ID: 15427471
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimental studies on 2-sulfanilamido-5-methylpyrimidine].
    HEPDING L; HOFFMANN A; WAHLIG H
    Arzneimittelforschung; 1960 Jun; 10():440-8. PubMed ID: 14401170
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical study of a new sulfonamide preparation: Gantrisin by Roche: 3,4-Dimethyl-5-sulfanilamido-isoxazol].
    LANGEMANN H
    Schweiz Med Wochenschr; 1950 Jan; 80(4):78-81. PubMed ID: 15404422
    [No Abstract]   [Full Text] [Related]  

  • 11. CLINICAL PHARMACOLOGY OF 2-SULFANILAMIDO-3-METHOXYPYRAZINE.
    HERTING RL; LOPEZ F; SCHERFLING E; SYLVESTER JC; WIEGAND R
    Antimicrob Agents Chemother (Bethesda); 1964; 10():554-61. PubMed ID: 14287992
    [No Abstract]   [Full Text] [Related]  

  • 12. [Influencing of the tubular function in renal excretion of 4-sulfanilamido-2, 6-dimethylpyrimidine].
    PORTWICH F; BUTTNER H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1956; 229(6):513-9. PubMed ID: 13407769
    [No Abstract]   [Full Text] [Related]  

  • 13. [PHARMACOKINETICS OF 2-SULFANILAMIDO-5-ETHYLPYRIMIDINE IN MAN].
    PLANCHER AC; SALVI G; BACUZZI E
    Farmaco Prat; 1964 Nov; 19():550-9. PubMed ID: 14234089
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical studies with 2-sulfanilamido-5-methoxypyrimidine].
    BUENGER P; KOCH G
    Arzneimittelforschung; 1961 Aug; 11():726-36. PubMed ID: 13874434
    [No Abstract]   [Full Text] [Related]  

  • 15. [THERAPEUTIC ACTION OF 2-SULFANILAMIDO-5-METHOXYPYRIMIDINE ON SUBACUTE AND CHRONIC CHOLECYSTITIS].
    VALENTI G; BELLODI G
    Policlinico Prat; 1964 Aug; 71():1273-7. PubMed ID: 14192188
    [No Abstract]   [Full Text] [Related]  

  • 16. [PHARMACOKINETICS AND CLINICO-THERAPEUTIC EFFECTIVENESS OF 4-SULFANILAMIDO-5,6-DIMETHOXYPYRIMIDINE].
    HITZENBERGER G
    Wien Klin Wochenschr; 1964 May; 76():330-4. PubMed ID: 14222129
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacology of 4-azophenyl-sulfanilamido-o-butylphenol.
    SAZONOVA NA
    Farmakol Toksikol; 1945; 8(2):49. PubMed ID: 21000679
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological and chemotherapeutic properties of 3,4-dimethyl-5-sulfanilamido-isoxazole.
    SCHNITZER RJ; FOSTER RH
    J Pharmacol Exp Ther; 1946 Sep; 88(1):47-57. PubMed ID: 20274525
    [No Abstract]   [Full Text] [Related]  

  • 19. [Our experience with the use of 3-sulfanilamido-2-phenylpyrazole in gynecological practice].
    MILNER A; RODRIGUEZ AE
    Sem Med; 1960 Aug; 117():604-6. PubMed ID: 13770963
    [No Abstract]   [Full Text] [Related]  

  • 20. 2-Sulfanilamido-3-methoxypyrazine: a new long-action sulfonamide.
    CESANA A; VENTURA R
    Panminerva Med; 1962 Apr; 4():184-7. PubMed ID: 13877775
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.